The sFlt-1/PlGF ratio of high-risk pregnant women for preeclampsia compared in singleton, twin, and triplet pregnancies

While the sFlt-1/PlGF ratio remains a valuable biomarker for preeclampsia prediction in singleton and twin pregnancies, its clinical utility in triplet pregnancies is limited. Further large-scale studies are needed to establish optimal cut-off values for multifetal pregnancies, particularly in triplets, to enhance risk stratification and clinical application.